Critical Contrast: Seagen (NASDAQ:SGEN) & Autolus Therapeutics (NASDAQ:AUTL)
Crexendo, Inc. (NASDAQ:CXDO – Get Rating) Director Steven G. Mihaylo acquired 26,800 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was acquired at an average cost of $1.48 per share, for a total transaction of $39,664.00. Following the transaction, the director now owns 11,259,055 shares of the company’s stock, […]